Daewoong Pharmaceutical announced on the 4th that it will increase the frequency of its global medical education program, the 'Nabota Master Class (NMC)', from twice a year to four times a year. The program invites medical professionals from regions such as Asia, Latin America, and the Middle East to participate in tailored academic programs.

Starting with the Asia-Pacific (APAC) medical education on the 29th of last month, events targeting medical professionals in Argentina and the Middle East are scheduled within the year. The expansion of NMC is analyzed as evidence of the global market's interest in Nabota.

In fact, exports have been steadily conducted. This year alone, major export contracts were signed in Asia and Latin America, including KRW 73.8 billion in Thailand and KRW 180 billion in Brazil. Additionally, the launch in key Middle Eastern countries such as Saudi Arabia and Qatar is progressing smoothly. Daewoong Pharmaceutical is enhancing the Nabota brand image by focusing on an educational platform that goes beyond simple procedure guidance to strengthen medical professionals' capabilities and facilitate academic exchange, in line with increasing global market demand. The intention is to imprint the competitiveness and status of K-beauty in the global market in a manner different from cosmetics and skincare.

Recently, the NMC was held in Seoul for three days starting from the 29th of last month. The 'Deep Nabota Master Class APAC' event concluded successfully with the attendance of over 40 medical professionals from five APAC countries. It was the first time a region-specific tailored education program reflecting the needs and trends of each country was introduced, sharing patient-tailored procedure approaches and complex procedure strategies. It is reported that the preference for visiting Korea itself is high among foreign medical professionals, as Korean tourism garners global interest. This NMC included detailed components such as theoretical lectures, hands-on sessions, tours of the Nabota plant, and Korean medical aesthetic field tours. The vivid education program, reflecting natural procedure effects, interest in K-beauty, and trends in non-invasive, complex, and customized procedures, received positive evaluations from foreign medical professionals. According to Daewoong Pharmaceutical, major sessions introduced Nabota's differentiated procedure method, Naboliift, and covered procedure know-how such as Naboglow, Violet, and Nabota complex procedures in depth, receiving great response from participants.

Customized sessions with local experts from the APAC region were also conducted. In the 'Case Sharing and Discussion' session, there was time to discuss customized procedures and cases by country and patient type, such as in Thailand and Indonesia. It was particularly evaluated as an opportunity for active exchange of opinions and information among medical professionals from different countries. Dr. Sirinya Prabriputaloong from Thailand, who participated as a speaker, expressed, “It was a meaningful time to share and exchange the latest clinical cases with global medical professionals,” and added, “Through the systematic program from the latest Nabota technology education to the Korean aesthetic field tour, it was an opportunity to gain new insights and grow.”

Yoon Joon-soo, Head of Daewoong Pharmaceutical's Nabota Business Division, stated, “We will further accelerate our global market strategy with Daewoong Pharmaceutical’s patient-centered treatment philosophy as the core strategy,” and added, “We plan to continuously develop the NMC program as a platform for academic exchange where global medical professionals can grow together, beyond simple procedure education.”

Popular News